ARTICLE | Company News
Lidak deal
November 7, 1994 8:00 AM UTC
LDAKA completed its previously announced agreement with Grelan Pharmaceutical Co. Ltd. (Tokyo) under which Grelan received an exclusive license to market and develop LDAKA's Lidakol anti-viral in Japa...